Analyst Ratings For Travere Therapeutics
Analyst Ratings For Travere Therapeutics
Travere Therapeutics的分析师评级
Decoding Analyst Ratings: A Detailed...Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Travere Therapeutics (NASDAQ:TVTX) in the last three months.
在过去的三个月里，8位分析师对Travere Therapeutics（纳斯达克股票代码：TVTX）发布了从看好到看淡的多元观点评级。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照，展示了情绪在过去30天中的演变情况，并将其与之前的月份进行比较。
Analysts have recently evaluated Travere Therapeutics and provided 12-month price targets. The average target is $18.38, accompanied by a high estimate of $23.00 and a low estimate of $12.00. This upward trend is apparent, with the current average reflecting a 16.7% increase from the previous average price target of $15.75.
Analysts have recently evaluated Travere Therapeutics and provided 12-month price targets. The average target is $18.38, accompanied by a high estimate of $23.00 and a low estimate of $12.00. This upward trend is apparent, with the current average reflecting a 16.7% increase from the previous average price target of $15.75.
Decoding Analyst Ratings: A Detailed...
分析师评级...
登录免费看全文
登录/注册
资讯热榜
更新时间